Work

Structure-based design of a decorin mimetic targeting TGF-β1

Year: 2026
Type: article
Abstract: Decorin mitigates fibrosis by docking onto transforming growth factor-β1 (TGF-β1), but its dense glycosylation and disulfide-rich caps hinder scalable manufacturing. Here we present miniDec, a 15-kDa decorin mimetic built from leucine-rich repeats 4–6 with newly designed, cysteine-free terminal caps. The aglycosylated construct folds efficiently in E. coli , yields >25 mg L⁻¹ after a two-step purification, and binds TGF-β1 with low-nanomolar affinity. miniDec blocks TGF-β-driven transdifferentiation of human corneal fibroblasts and, when applied topically, reduces corneal opacity, restores corneal surface regularity and accelerates epithelial wound closure in a mouse alkali-burn model, with efficacy comparable to that of full-length decorin at the fixed topical doses tested. The protein is non-cytotoxic to corneal epithelium and stromal cells. This new scaffold overcomes the production hurdles of the native proteoglycan while retaining its anti-fibrotic activity, establishing that decorin’s glycosaminoglycan chain, N-glycans and disulfide-bonded caps are dispensable for anti-fibrotic function in the cornea, and providing a manufacturable route to decorin-based therapy for corneal fibrosis.
Language: English
Subfield: Ophthalmology
Field: Medicine
Open Access status: gold
Estimated APC paid: $4,190
OpenAlex ID: W7235291402
FWCI:
Cites: 47
Cited by:
Related to: 10